Shares in commercial biotech company Allergy Therapeutics (AGY) had shot up by 7.76% to 26.40p at 1320 BST after the company announced positive top line results from phase II trials for a treatment for glass allergies.
Italian gaming regulators have approved FTSE 250 gaming technology outfit Playtech’s (PTEC) €846 million acquisition of Snaitech.
Shares in drug maker AstraZeneca (AZN) rose had risen by 2.52% to 5,373p at 1100 BST after the US Food and Drug Administration approved Lokelma, which is designed to treat high blood potassium levels.
FTSE 100 miner Glencore (GLEN) has seen its shares tumble 4.56% to 380.60p this afternoon on the back of news that it will be investigated by the Serious Fraud Office.
Carpetright (CPR) has announced plans to raise net proceeds of £60 million via a placing of new shares. Roughly a third of these funds will be used to cover the costs of its company voluntary arrangement and repay outstanding short term debts while the remainder will satisfy the capital expenditure requirements of the firm’s Revised Business Plan.
Pharma giant AstraZeneca (AZN) struggled during the first quarter with sales and earnings falling, Investment in new products, and a faster than anticipated decay of Crestor sales in Europe and Japan.
Geopolitical and supply concerns are helping to push the price back towards levels last seen in late 2014.
Shares in grocery delivery outfit Ocado (LON:OCDO) soared 278.8p to 827p (as at 14:50 BST) after the company announced that it had inked a deal with US retail giant Kroger. Under the arrangement, Kroger will use Ocado’s technology for food distribution to improve and centralise their online shopping experience. The financial effects of the deal are…
Shares in Fevertree (FEVR) had fallen by 7.38% to 2,709.25p at 1425 BST as the posh mixer maker failed to fizz.
Information services firm Experian (EXPN) had a strong finish to the year ended 31st March with total revenues for the 4th quarter up by 12%. as North American customer services returned to growth.